Lord, Abbett & Co
IMI

Lord, Abbett & Co’s Intermolecular, Inc. IMI Stock Holding History

Lord, Abbett & Co’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-73,732
Closed -$536K – 1123
2013
Q2 		$536K Buy
+73,732
New +$628K ﹤0.01% 1030

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lord, Abbett & Co's IMI Position: Q3 2013 in Review

Lord, Abbett & Co sold out of Intermolecular, Inc. (IMI) in Q3 2013, closing a stake of 73,732 shares — an estimated $536K sold.

Lord, Abbett & Co first reported a position in IMI in Q2 2013 and held it in 1 quarter. The position peaked at $536K in Q2 2013. 62 funds tracked by Wall St. Rank hold IMI as of Q3 2013.

  • Lord, Abbett & Co reported no remaining Intermolecular, Inc. position as of Q3 2013 after selling out during the quarter.
  • Lord, Abbett & Co sold 73,732 Intermolecular, Inc. shares in Q3 2013, an estimated $536K.
  • Lord, Abbett & Co first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 1 quarter.
  • Lord, Abbett & Co's Intermolecular, Inc. position peaked at $536K in Q2 2013.
  • 62 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2013.

Based on Lord, Abbett & Co's 13F filing for Q3 2013, filed 14 Nov 2013.